The company is commercialising novel Car T-cell therapy developed in New Zealand for cancer and other patients.
But third party open banking provider Akahu says there's more work to be done.
Kiwi startup’s early collaboration with OpenAI has raised its profile in its target North American market.
One of the few business sweeteners in Budget ’23 still puts us behind Australia.
Government asked to plug funding gap in commercialising deep tech research.
Shares rise after record FY23 results, maiden dividend declared.
Despite a global funding crunch, Kiwi tech investment rose 8.2% in 2022.
The Budget’s $451m investment into three new science hubs has been given the thumbs up but is it enough?
The health tech company is developing biomarkers to help treat patients with chest pain.
Space-tech company has a big year ahead with its first full-scale Z01 attitude control system launching in late 2023.